Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Barac

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Human Molecular Genetics|July 6, 2010
Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family StudyPhillip E Melton, Sue Rutherford, Venkata Saroja Voruganti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2020
Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular DiseaseSarju Ganatra, Sourbha S Dani, Robert Redd, et al.
JACC. Cardiooncology|October 10, 2022
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United StatesSarju Ganatra, Sourbha S Dani, Ashish Kumar, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Journal of Heart Failure|December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncologyTeresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Circulation. Cardiovascular Quality and Outcomes|September 13, 2023
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global InitiativeArco J Teske, Rohit Moudgil, Teresa López-Fernández, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditisDaniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Human Molecular Genetics|July 6, 2010
Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family StudyPhillip E Melton, Sue Rutherford, Venkata Saroja Voruganti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2020
Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular DiseaseSarju Ganatra, Sourbha S Dani, Robert Redd, et al.
JACC. Cardiooncology|October 10, 2022
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United StatesSarju Ganatra, Sourbha S Dani, Ashish Kumar, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Journal of Heart Failure|December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncologyTeresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Circulation. Cardiovascular Quality and Outcomes|September 13, 2023
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global InitiativeArco J Teske, Rohit Moudgil, Teresa López-Fernández, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditisDaniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
Pageof 17